2020
DOI: 10.1002/sim.8555
|View full text |Cite
|
Sign up to set email alerts
|

One‐stage individual participant data meta‐analysis models for continuous and binary outcomes: Comparison of treatment coding options and estimation methods

Abstract: A one‐stage individual participant data (IPD) meta‐analysis synthesizes IPD from multiple studies using a general or generalized linear mixed model. This produces summary results (eg, about treatment effect) in a single step, whilst accounting for clustering of participants within studies (via a stratified study intercept, or random study intercepts) and between‐study heterogeneity (via random treatment effects). We use simulation to evaluate the performance of restricted maximum likelihood (REML) and maximum … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(36 citation statements)
references
References 33 publications
0
36
0
Order By: Relevance
“…The primary analysis will be conducted by a one-stage approach [41], which means that all IPDs are modelled simultaneously while accounting for the clustering of participants within studies. The IPD of the primary outcome will be synthesized by a generalized linear mixed model [42].…”
Section: Discussionmentioning
confidence: 99%
“…The primary analysis will be conducted by a one-stage approach [41], which means that all IPDs are modelled simultaneously while accounting for the clustering of participants within studies. The IPD of the primary outcome will be synthesized by a generalized linear mixed model [42].…”
Section: Discussionmentioning
confidence: 99%
“…Analyses will be conducted in accordance with current recommendations for IPD meta-analyses [18][19][20][21][22][23] and will consider appropriate adjustment for baseline covariates (prognostic factors), handling of multiple treatment groups and control arms, missing data, [24][25][26][27] repeated measures, 28 29 timing of outcomes, randomisation, withinstudy treatment-related clustering 30 31 and non-adherence. Analysis populations will be based on the intention-totreat principle, including all randomised participants in the groups to which they were randomised, regardless of withdrawal or protocol compliance.…”
Section: Statistical Considerationsmentioning
confidence: 99%
“…CIs will be derived using an approach to account for uncertainty in variance estimates, such as the Hartung-Knapp-Sidik-Jonkmann 22 approach in the two-stage analysis, and the Kenward-Roger or Satterthwaite approach following the one-stage analysis. 21 After the meta-analysis, we will report estimated summary treatment effects, 95% CIs and 95% prediction intervals alongside forest plots with study-specific estimates of treatment effect. Heterogeneity will be assessed using the τ 2 statistic (variability of the true effect sizes under the random effects model, estimated using REML) and the I 2 statistic (proportion of total variability due to between-study heterogeneity).…”
Section: Effect Measuresmentioning
confidence: 99%
See 1 more Smart Citation
“…Other authors have noted that a +0.5/-0.5 coding may be preferable in some circumstances, by ensuring a common variance for treatment and control groups and improving maximum likelihood estimation 6,16 , particularly in random effect models where trials are few and the estimation of correlation between two random effects is problematic 14 . Another option is "studyspecific centering" (coding 1/0 minus the study-specific proportion of participants in the treatment group) that may reduce the downward bias of between-study variance when using maximum likelihood estimation 16 . Overall, few analyses showed any clear evidence of treatment-covariate interaction, generally having wide confidence intervals.…”
Section: Random Interactionmentioning
confidence: 99%